TrialAntimicrobial agents and chemotherapy2022

Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants.

Aline Barth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.